ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
11.31 EUR
-0.13 (-1.14%)
IBAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of IBAB while its profitability can be described as average. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
In the past year IBAB had a positive cash flow from operations.
Of the past 5 years IBAB 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of 2.71%, IBAB perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
The Return On Equity of IBAB (14.29%) is better than 79.37% of its industry peers.
IBAB has a better Return On Invested Capital (15.54%) than 93.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IBAB is below the industry average of 9.81%.
The 3 year average ROIC (6.20%) for IBAB is below the current ROIC(15.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
Looking at the Profit Margin, with a value of 2.85%, IBAB is in line with its industry, outperforming 42.86% of the companies in the same industry.
IBAB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.48%, IBAB perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
In the last couple of years the Operating Margin of IBAB has grown nicely.
Looking at the Gross Margin, with a value of 31.21%, IBAB is doing worse than 85.71% of the companies in the same industry.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBAB is creating value.
The number of shares outstanding for IBAB has been increased compared to 1 year ago.
Compared to 5 years ago, IBAB has less shares outstanding
IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
IBAB has an Altman-Z score of 1.63. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IBAB (1.63) is worse than 66.67% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
The Debt to Equity ratio of IBAB (0.23) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.63 |
ROIC/WACC2.16
WACC7.19%
2.3 Liquidity
IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a worse Current ratio (0.94) than 85.71% of its industry peers.
A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
With a Quick ratio value of 0.62, IBAB is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.86%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.99% on average over the past years.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.01% yearly.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.72% yearly.
Based on estimates for the next years, IBAB will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y151.4%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue Next Year23.62%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.84, which indicates a rather expensive current valuation of IBAB.
79.37% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.49. IBAB is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 10.79, which indicates a very decent valuation of IBAB.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaper than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, IBAB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.84 | ||
| Fwd PE | 10.79 |
4.2 Price Multiples
IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 90.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.91 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBAB's earnings are expected to grow with 67.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)4.98
EPS Next 2Y108.36%
EPS Next 3Y67.72%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.50%.
IBAB's Dividend Yield is a higher than the industry average which is at 2.14.
Compared to the average S&P500 Dividend Yield of 2.31, IBAB is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EBR:IBAB (12/8/2025, 5:28:50 PM)
11.31
-0.13 (-1.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap342.47M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.62 (29.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.5% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.27%
PT rev (3m)-7.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.53%
EPS NY rev (3m)-18.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2%
Revenue NY rev (3m)6.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.84 | ||
| Fwd PE | 10.79 | ||
| P/S | 0.57 | ||
| P/FCF | N/A | ||
| P/OCF | 123.01 | ||
| P/B | 2.88 | ||
| P/tB | 3.63 | ||
| EV/EBITDA | 7.91 |
EPS(TTM)0.57
EY5.04%
EPS(NY)1.05
Fwd EY9.27%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.81%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.13
PEG (5Y)4.98
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.63 |
F-Score7
WACC7.19%
ROIC/WACC2.16
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y151.4%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year23.62%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year216.01%
EBIT Next 3Y67.42%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 19.84 and the Price/Book (PB) ratio is 2.88.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 151.4% in the next year.